Diagnostic, Progressive and Prognostic Performance of M6A Methylation RNA Regulators in Lung Adenocarcinoma

International Journal of Biological Sciences - Canada
doi 10.7150/ijbs.39046
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ivyspring International Publisher

Related search

Profiles of M6A RNA Methylation Regulators for the Prognosis of Hepatocellular Carcinoma

Oncology Letters
Cancer ResearchOncology
2020English

A Diagnostic Panel of DNA Methylation Biomarkers for Lung Adenocarcinoma

Frontiers in Oncology
Cancer ResearchOncology
2019English

Fate by RNA Methylation: M6A Steers Stem Cell Pluripotency

Genome Biology
2015English

Prognostic Significance of Grading in Lung Adenocarcinoma

Cancer
Cancer ResearchOncology
2010English

Changes in M6A RNA Methylation Contribute to Heart Failure Progression by Modulating Translation

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2019English

LAPTM4B Is a Novel Diagnostic and Prognostic Marker for Lung Adenocarcinoma and Associated With Mutant EGFR

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Precise Localization of M6A in Rous Sarcoma Virus RNA Reveals Clustering of Methylation Sites: Implications for RNA Processing.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1985English

Inactivation of P16 by Methylation in Human Lung Adenocarcinoma

Nature Genetics
Genetics
2001English

Prognostic and Therapeutic Potential of Adenylate Kinase 2 in Lung Adenocarcinoma

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy